During the past decade, UNC Project conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Project" #1 sponsor was "University of North Carolina, Chapel Hill" with 9 trials, followed by "UNC Lineberger Comprehensive Cancer Center" with 5 trials sponsored, "AIDS Clinical Trials Group" with 4 trials sponsored, "International Partnership for Microbicides, Inc." with 3 trials sponsored and "AIDS Malignancy Consortium" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Project" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Baylor College of Medicine" with 2 trials as a collaborator and "Fogarty International Center of the National Institute of Health" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "UNC Project" are "HIV Infections" (11 trials), "HIV" (5 trials), "Fistula" (2 trials), "AIDS-Related Human Papillomavirus Infection" (1 trials) and "CIN 2/3" (1 trials). Many other conditions were trialed in "UNC Project" in a lesser frequency.

Most popular intervention types in "UNC Project" are "Drug" (9 trials), "Other" (7 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapivirine" (2 trials), "Emtricitabine" (2 trials), "Emtricitabine/Tenofovir disoproxil fumarate" (2 trials), "Laboratory Biomarker Analysis" (2 trials) and "Nevirapine" (2 trials). Other intervention names were less common.

The vast majority of trials in "UNC Project" are 13 trials for "Female" genders, 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UNC Project". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in UNC Project, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Project, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".